Charlotte Duch Lynggaard

10PUBLICATIONS
39CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Oral and maxillofacial surgeryDental therapeutics, pharmacology and toxicologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 03, 2025
Long-term Effectiveness and Safety of Mesenchymal Stromal Cell Therapy for Radiation-Induced Hyposalivation in Head and Neck Cancer Survivors: A Randomized Phase II Trial.

Amanda-Louise Fenger Carlander, Kathrine Kronberg Jakobsen, Tobias Todsen

|May 01, 2024
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline.

Douglas E Peterson, Shlomo A Koyfman, Noam Yarom

|Apr 05, 2024
Long-Term Outcome Following Treatment With Allogeneic Mesenchymal Stem/Stromal Cells for Radiation-Induced Hyposalivation and Xerostomia.

Kathrine Kronberg Jakobsen, Charlotte Duch Lynggaard, Natasja Paaske

|Mar 05, 2024
Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.

Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Tobias Todsen

|Dec 10, 2022
Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients.

Charlotte Duch Lynggaard, Rosa Jersie-Christensen, Morten Juhl

|Apr 29, 2022
Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial.

Charlotte Duch Lynggaard, Christian Grønhøj, Siri B Jensen

Pageof 2